Harbour Asset Management Boosts Ryman Healthcare Holding to 6.66% After $91.7 Million in Market Purchases

Harbour Asset Management's Ryman Healthcare Stake Surpasses 67.6 Million Shares

As of 30 June 2026, Harbour Asset Management Limited holds 67,653,109 ordinary shares in Ryman Healthcare, equating to 6.661% of the total ordinary share class of 1,015,729,081 shares. This is an increase from 51,514,714 shares, or 5.575%, reported in Harbour's previous disclosure on 4 March 2025. The rise of over 1% in percentage holding triggered a mandatory disclosure under the Financial Markets Conduct Act 2013, which requires substantial product holders to notify NZX Limited and the listed company when their stake changes by 1% or more.

The net increase of roughly 16.1 million shares over approximately 16 months highlights a deliberate and sustained accumulation approach by the fund manager. Additionally, the total shares on issue expanded from 924,051,375 at the last disclosure to 1,015,729,081 at this disclosure, indicating that Ryman Healthcare issued more shares during this time. Harbour's buying activity was sufficient to increase its proportional stake despite the larger share base.

$91.7 Million in Purchases Offset by $49.3 Million in Sales Since March 2025

The disclosure details Harbour Asset Management’s on-market purchases of 35,577,034 Ryman Healthcare shares for $91,671,745.55 in gross consideration between 4 March 2025 and 30 June 2026. Over the same period, Harbour sold 19,438,639 shares for $49,312,079.26 gross, resulting in a net addition of approximately 16,138,395 shares and an increase in holding from 5.575% to 6.661%.

These figures reflect Harbour’s active trading mandate rather than a simple buy-and-hold strategy. Fund managers typically trade continuously across multiple client accounts, and the gross figures represent the aggregate activity across Harbour’s client base. Overall, Harbour’s portfolio positioning shifted significantly toward increased exposure to Ryman Healthcare during this period.

BNZ Investment Services Limited Holds Separate 1.620% Stake Managed by Harbour

The disclosure also reveals BNZ Investment Services Limited (BNZIL), a wholly-owned subsidiary of BNZ Investments Limited, holds 16,451,433 Ryman Healthcare shares, representing 1.620% of the total share class. These shares are managed by Harbour Asset Management under an investment management agreement, forming part of Harbour’s broader relevant interest but representing a distinct beneficial ownership.

Since the previous disclosure, BNZIL conducted on-market purchases of 8,221,252 shares for $21,971,060.27 and sales of 4,497,202 shares for $11,057,573.27. Combined, Harbour’s direct holdings and BNZIL-managed assets represent over 8% of Ryman Healthcare’s ordinary shares, although the formal disclosed substantial holding for Harbour stands at 6.661%.

FirstCape’s Indirect Control Over Harbour’s Voting and Disposal Rights in Ryman

The corporate structure disclosed shows Harbour Asset Management Limited as a wholly-owned subsidiary of FirstCape, giving FirstCape indirect voting and disposal powers over Ryman Healthcare shares through Harbour. This is a standard institutional arrangement where the parent entity holds relevant interest in shares managed by subsidiaries, while day-to-day investment decisions are made by the fund manager.

Harbour holds the authority to exercise voting rights and control acquisition or disposal of shares under investment powers granted by trust deeds or management agreements. This structure is common among New Zealand and Australian fund managers and does not indicate unusual governance. The disclosure was certified by Madeleine Pumphrey of JBWere on Harbour’s behalf.

On-Market Transaction Procedures and Custodian Details for Ryman Shares

The disclosure notes that registered holders of Ryman shares were listed as "Unknown" at the time of on-market purchases, which is typical between trade execution and settlement. After registration, shares are held by nominees or custodians on Harbour’s behalf, standard practice for institutional investors using omnibus or nominee accounts.

For sales, registered holders were various nominees or custodians for Harbour at disclosure, with post-transfer holders listed as "Unknown." These procedural details reflect institutional settlement mechanics and do not affect the substantive change in holdings. Investors should focus on net holding changes rather than custodian specifics.

Ryman Healthcare’s Share Base Growth Contextualizes Harbour’s Accumulation

The total number of Ryman Healthcare ordinary shares increased from 924,051,375 on 4 March 2025 to 1,015,729,081 on 30 June 2026, a rise of about 91.7 million shares or 9.9%. This suggests Ryman conducted capital-raising or issued additional shares, which typically dilutes existing shareholders who do not participate.

Despite this dilution, Harbour’s percentage holding rose from 5.575% to 6.661%, indicating its net buying more than offset dilution. This buying amid an expanding share register may be viewed as a strong confidence signal from a major New Zealand institutional manager, though accumulation can reflect diverse client mandates and portfolio rebalancing rather than a single investment thesis.

Implications of Disclosure Timing for Ryman’s Institutional Shareholders

The 30 June 2026 relevant event date coincides with the financial half-year end for many New Zealand and Australian institutional investors, a common time for portfolio rebalancing and mandate reviews. The disclosure filed on 1 July 2026 suggests the 1% threshold was crossed during the final trading session of the half-year or as a cumulative effect of June transactions.

Harbour’s last disclosure was on 4 March 2025, meaning over 15 months passed between substantial holder notices. During this time, Harbour actively traded Ryman shares on both sides, as shown by the gross purchase and sale figures. The absence of earlier disclosures indicates the net position change remained below 1% until this recent increase.

Ryman Healthcare’s Role in the Retirement Village Sector and Market Interest

Ryman Healthcare is a leading retirement village and aged care operator in New Zealand and Australia, managing integrated villages with independent living, serviced apartments, and aged care facilities. It is a longstanding NZX 50 constituent and dual-listed on the ASX, attracting institutional investors from both countries.

Harbour’s increased accumulation, as revealed in this update, may draw attention from market participants tracking substantial shareholder register changes as indicators of institutional sentiment. The announcement shows Harbour as a consistent net buyer over 15 months, though investors should perform their own due diligence and consider all factors affecting Ryman’s outlook before making investment decisions. The immediate share price impact was not clear from public information.

Future Disclosure Requirements and Monitoring Ryman’s Shareholder Register

Under the Financial Markets Conduct Act 2013, Harbour must disclose further substantial holdings if its stake in Ryman changes by 1% or more from the current 6.661%, whether through accumulation or selling. Investors and analysts monitoring Ryman’s register will watch for filings indicating if Harbour’s accumulation continues or reverses.

The disclosure names no other parties required to give notices under the Act for these financial products, limiting the current filing to Harbour and its related entities. As Ryman advances its business across New Zealand and Australia, shifts in its institutional shareholder base, including movements by other substantial holders, will be important data points for market observers.